IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.606
EU - Europa 1.837
AS - Asia 1.813
SA - Sud America 251
AF - Africa 228
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.739
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.524
RU - Federazione Russa 984
SG - Singapore 955
CN - Cina 466
IT - Italia 325
BR - Brasile 207
IE - Irlanda 191
CI - Costa d'Avorio 147
VN - Vietnam 137
KR - Corea 85
DE - Germania 71
GB - Regno Unito 58
CA - Canada 50
UA - Ucraina 49
IN - India 44
NL - Olanda 36
SN - Senegal 25
FI - Finlandia 23
MX - Messico 23
BJ - Benin 22
HK - Hong Kong 22
PL - Polonia 22
JP - Giappone 20
AR - Argentina 17
BD - Bangladesh 16
CZ - Repubblica Ceca 16
SE - Svezia 16
NG - Nigeria 14
ES - Italia 13
ZA - Sudafrica 13
ID - Indonesia 12
IQ - Iraq 12
FR - Francia 9
TR - Turchia 9
CH - Svizzera 8
CO - Colombia 6
PE - Perù 6
EC - Ecuador 5
PY - Paraguay 5
UZ - Uzbekistan 5
IR - Iran 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MA - Marocco 3
SA - Arabia Saudita 3
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
PK - Pakistan 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
QA - Qatar 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
Totale 6.739
Salva come PNG Salva come JPEG
Città #
Singapore 583
Moscow 503
Santa Clara 472
Dallas 419
Dublin 191
Ashburn 183
Chandler 179
Hefei 170
Abidjan 147
Los Angeles 147
Chicago 108
Seoul 84
Beijing 76
Boardman 69
Civitanova Marche 65
New York 57
Ho Chi Minh City 51
Cambridge 50
Jacksonville 50
Lawrence 50
Catania 48
Andover 38
Buffalo 37
Nanjing 28
Bremen 26
São Paulo 26
Amsterdam 25
Dakar 25
Des Moines 24
Cotonou 22
Hanoi 22
Hong Kong 21
Brooklyn 20
Denver 20
Tokyo 20
Warsaw 20
Toronto 19
Lappeenranta 18
Milan 17
Poplar 17
Saint Petersburg 17
Chennai 16
Stockholm 15
Wilmington 15
Abuja 14
Brno 13
Orem 13
Rome 13
Haiphong 12
Houston 12
San Francisco 12
Council Bluffs 11
Phoenix 11
Washington 11
London 9
Mexico City 9
Montreal 9
Nanchang 9
Atlanta 8
Johannesburg 8
Manchester 8
Ankara 7
Querétaro 7
Baghdad 6
Frankfurt am Main 6
Mumbai 6
Redwood City 6
Rio de Janeiro 6
Shenyang 6
Arequipa 5
Calgary 5
Genoa 5
Hebei 5
Messina 5
Munich 5
Palermo 5
Redondo Beach 5
San Mateo 5
Tianjin 5
Turin 5
Turku 5
Bernareggio 4
Bắc Ninh 4
Changsha 4
Columbus 4
Da Nang 4
Dhaka 4
Dong Ket 4
Misterbianco 4
Pune 4
San Jose 4
Seattle 4
Tehran 4
The Dalles 4
Bari 3
Bishkek 3
Boston 3
Brussels 3
Charlotte 3
Curitiba 3
Totale 4.572
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 115
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 112
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 108
Lung clearance index: A new measure of late lung complications of cancer therapy in children 107
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 105
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 104
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 104
Minor pulmonary malformations in a child 104
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 104
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 101
Biomarkers in pediatric lung diseases including cystic fibrosis 100
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 99
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 97
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 97
Lactoferrin: Cytokine modulation and application in clinical practice 97
Hypertransaminasemia in children is not always as simple as it seems 97
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 96
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 96
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 95
Cetirizine use in childhood: An update of a friendly 30-year drug 95
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 93
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 91
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 90
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 89
Serum YKL-40 in children with asthma 89
Novel therapeutic targets for allergic airway disease in children 88
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 88
Antihistamines: ABC for the pediatricians 87
HMGB1 values and response to HBV vaccine in children with celiac disease 86
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 84
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 83
Antihistamines in children and adolescents: A practical update 83
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 81
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 79
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 79
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 77
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 77
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 77
Exhaled breath temperature in astmatic children 76
Lung clearance index for evaluation of late complications of cancer therapy in children 76
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 75
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 73
Liver disease in Cystic Fibrosis: an update 72
Severe Kawasaki disease in a 3-month-old patient: a case report. 72
Genetic disorders of surfactant deficiency and neonatal lung disease 70
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 69
Severe disease in Cystic Fibrosis and fecal calprotectin levels 69
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 69
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 68
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 68
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 68
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 67
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 66
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 66
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 65
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 65
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 64
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 62
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 61
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 60
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 60
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 59
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 58
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 57
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells 57
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 56
The immunomodulatory role of vitamin D in respiratory diseases 55
Lower airway microbiota 55
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 55
The role of skin infections in atopic dermatitis in children 54
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 54
Upper and lower airways diseases in childhood 53
Type 2 inflammation in cystic fibrosis: New insights 51
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 49
Protracted bacterial bronchitis: more to know 47
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 47
Nasal microbiome in chronic rhinosinusitis 45
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management 45
HMGB1 as a Biomarker of Inhaled Corticosteroid Treatment Response in Moderate-Severe Asthmatic Children: A Single Center Pilot Study 41
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 35
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 35
Pidotimod in allergic diseases 34
Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis 33
Correlation between RINT values and echocardiographic indices in pre-school children with chronic cough and wheezing 32
Oral immunotherapy in children with allergic diseases: past, present and future 31
Efficacy of sublingual allergen-specific immunotherapy in children evaluated by the measurements of bronchial and nasal nitric oxide. Preliminary results 31
Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators 30
COVID-19 ocular manifestation in children 30
Calprotectin in cystic fibrosis: A new marker of flogosis 29
Effectiveness of omalizumab in two children with severe vernal keratoconjunctivitis 26
Corrigendum to “Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor”. J Pediatr. 2024 Jun 28; 274:114176 26
Three Consecutive Cases of Double Aortic Arch with Various Clinical Onset 26
Measurement of nitric oxide and assessment of airway diseases in children: An update 25
Lobar Emphysema in a 7-year-old girl: Acquired Form or Late Onset Congenital Form? 24
Influence of early growth on childhood lung function assessed by magnetic resolution imaging and spirometry. The Generation R Study 24
Evaluation of Oxidative Stress Degree in Patients Affected by Cystic Fibrosis or Non-CF Bronchiectasis through the Measurement of 8-isoprostane 24
Plasmatic Amino Acids in Patients with Cystic Fibrosis: An Observational Study 23
Fever and tick-borne disease 22
COVID-19 Pneumonia in Children: From Etiology to Management 22
An overview of HMGB1 and its potential role as a biomarker for RSV infection 22
Totale 6.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.011
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.625 47 188 68 112 292 310 48 33 75 148 163 141
2025/20263.624 265 330 595 366 1.056 1.012 0 0 0 0 0 0
Totale 6.910